Author(s)

Petya Trendafilova¹, Tatyana Benisheva², Borislav Borissov³

¹Department of Health Technology Assessment, Faculty of Public Health, Medical University—Sofia,Sofia,Bulgaria.
²Department of Health Policy and Management, Faculty of Public Health, Medical University—Sofia, Sofia, Bulgaria.
³Prescriptia Ltd., Sofia, Bulgaria.

The aim of this study is to trace and analyze the public reporting of medicinal products’ expenditure paid by the National Health Insurance Fund (NHIF) for outpatient care since its establishment (June 2000) in Bulgaria. The analysis of financing from the NHIF for the period 2000-2016 shows an increasing expenditure of medicinal products for outpatient care. There is a big increase of the medicinal products’ spending paid by the NHIF budget for 2012 - 495.5 million BGN (which means 104.5 (21%) million BGN more than the previous 2011. As a result of this analysis it was found out that there is scarce fragmentary chronological public reporting traceable by indicators for outpatient care expenditure since the National Health Insurance Fund establishment. The reports published on the NHIF’s website provide partial information only about total expenditure for health insurance payments for medicinal products for outpatient care.

 

Analysis, Expenditure for Medicinal Products, Outpatient Care, NHIF

Trendafilova, P. , Benisheva, T. and Borissov, B. (2016) Analysis of Medicinal Products’ Expenditure Reimbursed by the National Health Insurance Fund in Bulgaria for Outpatient Care. Open Journal of Social Sciences, 4, 27-32. doi: 10.4236/jss.2016.45005.